Key Takeaways
- Multiple headwinds converged in Q3: Reformulation at a key India Tier 1 account, GST disruption, US tariffs, and buoyant fatty alcohol prices all hit at once, yet the company held profit flattish and delivered positive volume growth.
- AMET peak volumes are gone for good: A backward-integrated competitor and Egypt currency depreciation mean the 35% drop from peak will not reverse; management is working to balance this with other markets.
- US tariff normalization is a tailwind: The reciprocal tariff cut from 50% to 18% restores competitiveness, and customers are restarting suspended pipeline projects, with an uptick expected from late Q4.
- Gross margin per kg rebounded to ~INR53.5 from ~INR49 in H1, driven by TRI-K performance and India mix, though sustainability depends on US demand clarity and Tri-K trajectory.
- What to watch next quarter: Whether reformulation alternatives get commercialized and win back volumes, whether US demand concerns flagged by two top customers materialize, and whether the 6%-8% volume guidance holds once geopolitical flux settles.
The Reformulation Shock
- Root cause: Persistently high fatty alcohol prices relative to crude petroleum derivatives created an unusually wide and prolonged spread, forcing Tier 1 customers to reformulate away from Galaxy's surfactants. Management calls this a temporary, forced adjustment.
- India impact: The entire YoY degrowth in India Performance Surfactants came from reformulation at a few Tier 1 accounts, partially offset by strong Tier 2 and Tier 3 growth.
- Fully reflected in Q3: Based on discussions with customer top leadership, "most of what they had to do, they have done," so the reformulation hit is now fully in the numbers.
- Recovery path: Galaxy has developed alternate surfactant systems and formulations aligned to the new reformulations; approvals are underway and commercialization is expected to start in Q4 FY26, with major impact only next year.
- Volume recapture: Management expects to get a good portion of reformulation volumes back through a strategic arrangement with the customer, once alternate feedstock and formulations are ready. EBITDA realization on reformulation should be largely similar to Performance Surfactants.
Natarajan: "There's no of grabbing market share. It is that we lost volumes to the reformulation. My customers, obviously, they reform because there's someone else who was making that supply. And the reason why we are confident that we'll be able to get a good portion of the volumes back is in terms of the strategic arrangement we have with the customer and the volumes that went out from us would come back once we are ready with that particular alternate feedstock, alternate formulation."
AMET: Structural Reset, Not a Cycle
- What changed: A backward-integrated local competitor in Egypt took share from Tier 1 customers, while Egypt's currency depreciation (from INR15-16 to INR45 per dollar) and high inflation gave local players a significant cost advantage with cheaper product formats and pricing.
- Peak is unrecoverable: Management explicitly stated AMET will not return to peak volumes within the next year, calling it a new scenario rather than a temporary dip.
- Offset strategy: Volumes are recovering from Q4 onwards as significant traction has been regained from most customers; the team is working to balance the AMET shortfall with growth in other markets while managing credit risk carefully.
Natarajan: "No, we don't expect it to reach the peak because we very clearly have told that we have had a new scenerio competition, where you have a person who is backward integrated and who has also taken share from the Tier 1 customers."
US Tariffs: The Overhang Begins to Lift
- Tariff normalization: The reciprocal tariff on Indian exports was reduced from 50% to 18% following a bilateral update between India and the US, restoring competitiveness and creating a more level playing field.
- How Galaxy managed the interim: Some business was moved to Egypt; for products that could not be moved, management either absorbed 50% of the tariff or dropped the business if it would be cash-negative. As duties have come down, once current contracts end, margins can be reinstated.
- Demand caution: For the first time, two of the biggest US customers flagged concerns about demand issues in the US, introducing uncertainty even as tariffs ease.
- Pipeline restart: Customers are restarting evaluation of suspended pipeline projects; uptick in demand for tariff-impacted products is expected from end of this year, with more visible impact next year.
Customer Mix & Volume Resilience
- Tier 2/3 share rose: Local and niche players' share increased from 39% to 44% (9-month basis), partly a denominator effect from MNC volume declines, but also reflecting deep engagement with Tier 2, Tier 3, and D2C customers. Management is not deliberately pivoting away from Tier 1.
- India specialty surge: More than 35% volume growth YoY, driven by broadening the franchise with non-Tier 1 customers, cushioning the Performance Surfactants decline.
- Rest of World growth: Mid-single digit volume growth YoY, with Latin America and Europe posting growth, partially offsetting tariff-induced softness in North American specialty exports from India.
- Volume guidance held, barely: The 6%-8% volume guidance is maintained, but management declined to confirm it outright, calling it "dangerous to change guidance when things are in such a state of flux."
Natarajan: "See, volume guidance, we talked always about 6% to 8%, ? So it's actually very dangerous to change guidance when things are in such a state of flux. That's the reason why I'm not courageous enough to do that because I don't want to be revising the guidance has to give more clarity."
Margins & Mix
- Gross margin recovery: Gross margin per kg rose to INR53-53.5 in Q3 from ~INR49 in H1, driven by strong TRI-K (Prestige Specialties) performance and mix impact from India sales. The H1 decline from ~INR52.5 was driven by tariffs stalling US business, forcing urgent rejigging to other markets at suboptimal pricing.
- Sustainability question: Management needs clarity on US demand (customer-flagged concerns) and Tri-K performance trajectory before confirming gross margin sustainability; more clarity expected by next quarter's call.
- EBITDA improvement drivers: Strong volume growth from non-Tier 1 accounts, improved contribution realization from Masstige in India and Prestige specialty products in rest of world, incremental service income from EPC projects, lower logistics costs, and cost efficiency initiatives.
- Exceptional item: INR11.9 crores recognized related to the new labor code for enhanced gratuity and leave encashment calculations, a one-time prudent provision.
Specialty & Innovation Pipeline
- Leave-on segment push: Five new products launched under GalSORB and SunBliss ranges in sun care and leave-on categories at cosmetics Bangkok in November; second-generation molecules designed for high photostability, strong efficacy at low dosage, broad-spectrum UV protection including blue light defence, and improved sensory performance.
- Commercialization timeline: Production, sales, and commercialization of the five new Leave-on products expected to ramp up from Q4 FY26 onwards, to be sold in India and out of India.
- Beauty segment focus: The HPC market remains highly skewed toward cleaning applications; Galaxy is focusing on beauty (skin cream, skin lotion ingredients) but will be choosy about which Leave-on categories to enter to sustain growth and profitability.
- Rebranding: In January 2026, Galaxy refreshed its brand identity after 45 years, reinforcing focus on long-term partnerships, responsible innovation, and sustainable value creation, with portfolio expanding beyond home and personal care into beauty, derma, and wellness.
Raw Material & Feedstock Dynamics
- Fatty alcohol prices: The unusually wide and prolonged spread between fatty alcohols and crude petroleum kept reformulation risk elevated; prices began to firm again in January, consistent with seasonal patterns and festival-linked demand.
- Palm kernel oil: Remains a factor to monitor; brief softening in November due to record palm oil production and stock buildup, but easing was short-lived.
- Volatility is the problem: Management noted that a steady rise or fall is easy to manage, but frequent fluctuation makes business difficult because customers delay deals when prices fall and buy only short-term when prices rise, expecting another reversal.
- Structural clarity: Need to wait at least six months (till next October) to understand if the price shift is structural; crude petroleum price correction could impact the farm value chain due to positive correlation with palm oil; initial discussions indicate good production scenario this year, which could be bearish.
Natarajan: "If it's been peculiar into a particular rising situation or a fall, I think it's very easy to manage the business. If it's a situation where it keeps fluctuating very frequently, the frequency is what is a problem today."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| India reformulation commercialization | Alternate surfactant systems and formulations to be commercialized; major impact only next year | Starts Q4 FY26 |
| AMET volume recovery | Volumes recovering from Q4 onwards; peak volumes will not return within 1 year | Q4 FY26 onward |
| US tariff-impacted demand uptick | Customers restarting pipeline projects; demand uptick expected | Late Q4 FY26 / Q1 FY27 |
| New Leave-on product ramp-up | 5 new products (GalSORB, SunBliss) to ramp production, sales, and commercialization | Q4 FY26 onwards |
| EPC project completion | Plant commissioned; Galaxy reports offtake volumes for North America requirement | Q4 next financial year |
| Volume guidance | 6%-8% maintained, contingent on positive geopolitical developments | Next 2 years |
| Fatty alcohol price structural clarity | Need to wait for next October production data to assess if shift is structural | ~6 months |
Key Metrics
| Metric | Q3 FY26 |
|---|---|
| Consolidated volumes | Stable YoY |
| Performance Surfactants volume growth | High single-digit decline YoY |
| Specialty segment volume growth | High single-digit growth YoY |
| EBITDA before exceptional items | ₹124 cr, +13% YoY vs ₹110 cr in Q3 FY25 |
| EBITDA per metric ton | ₹20,156, vs ₹17,527 in Q3 FY25 |
| 9M FY26 EBITDA before exceptional items | ₹376 cr, flat YoY vs ₹375 cr in 9M FY25 |
| 9M FY26 EBITDA per metric ton | ₹19,126, vs ₹19,272 in 9M FY25 |
| Exceptional items (new labor code) | ₹11.9 cr, one-time gratuity and leave encashment provision |
| India volume growth | Mid-single digit YoY |
| India Performance Surfactants volume growth | ~4% decline YoY |
| India specialty volume growth | More than 35% YoY |
| AMET volume growth | Double-digit decline in high teens YoY |
| Rest of World volume growth | Mid-single digit YoY |
| India market average price correction | ~8% for Q3, driven by cautious buying on feedstock softening |
| U.S. reciprocal tariff on Indian exports | Reduced from 50% to 18%, announced during the quarter |
| AMET volumes vs peak | Down 35% from peak quarterly volumes |
| Non-Tier 1 customer share of revenue mix | 47% in Q3, up from 40%; 44% on 9M basis, up from 39% |
| Gross margin per kg | ₹53 to ₹53.5 in Q3, vs ~₹49 in H1 FY26 (per an analyst's math) |
| New products launched (GalSORB, SunBliss range) | 5 new products, commercialization from Q4 FY26 |
| Volume guidance | 6% to 8%, maintained but management cautious given flux |